TabletsTablets
Schedule H (Prescription Required)Orthopedic & Joint CareCode: 2178

Meloxicam 7.5mg Tablets

Generic Formulation:Meloxicam 7.5mg Tablets BP
Pack Size:10's

MRP Under Process

Official PMBI MRP is being updated for catalog code 2178.

Locate Jan Aushadhi Kendra
Clinical InformationReport Error

Clinical Overview

Meloxicam Tablets (7.5mg, 15mg) is an oral enolic acid oxicam NSAID with preferential COX-2 selectivity on the WHO Model List of Essential Medicines. It provides potent articular anti-inflammatory, analgesic, and antipyretic activity while sparing gastric mucosal COX-1 at lower therapeutic doses (7.5 mg daily). Indicated for symptomatic relief of osteoarthritis (7.5-15 mg once daily), rheumatoid arthritis (15 mg once daily), and ankylosing spondylitis.

Active Pharmaceutical Ingredients

AI-assistedClinical summary synthesized from pharmacopoeial references (CDSCO, WHO EML, IP/BP/USP). Not clinician-reviewed. Drug code 2178.Report inaccuracy

Usage Guidelines

Take orally once daily with food or water: start at 7.5 mg once daily; can be increased to a maximum of 15 mg once daily for severe arthritis. Swallow whole.

General Administration Advice: Adhere strictly to the prescribed dosage, frequency, and treatment course. For oral medications, swallow with sufficient water. Never stop antibiotics, psychiatric medications, or antihypertensives abruptly without clinical direction.

Possible Side Effects

Common: Dyspepsia, nausea, diarrhea, abdominal pain, headache, dizziness, edema. Rare/Severe: Gastrointestinal ulceration/bleeding, myocardial infarction, stroke, and acute kidney injury.

*Note: Individual physiological responses vary. While many patients experience few or no side effects, notify your treating physician if adverse reactions persist or if hypersensitivity (angioedema, skin rash, dyspnea) occurs.

Precautions & Warnings

Black Box Warning: Cardiovascular thrombotic risk and GI bleeding. Lowest effective dose should be used. Contraindicated in active peptic ulcer disease, CABG surgery, and severe renal failure.

Schedule H (Prescription Required)

This medication is scheduled under statutory drug regulatory frameworks (CDSCO / Drugs & Cosmetics Rules). Dispensing requires a valid medical prescription from a registered medical practitioner. Self-medication or unsupervised dosage adjustment carries significant clinical risks.

Medical Disclaimer: Statutory Clinical Disclaimer: The information provided is for educational and price-transparency purposes only and does not constitute medical advice, clinical diagnosis, or analgesic treatment guidance. Always consult a registered physician or orthopedic specialist before taking pain relievers, anti-inflammatory medications, or anti-arthritic therapies.